Erectile Dysfunction

 

Drug-Induced Erectile Dysfunction

                        The drugs may have a direct effect or may act indirectly through bringing about nerve, vascular or hormonal imbalance.

                        As many as 25 percent of cases of erectile dysfunction are related to medication side effects. If you are taking any of these drugs, please tell your doctor. At the same time, many patients only know their medications by their trade names, which is why it becomes so essential for you to tell the doctor all the medications you are on. 

                     The list given below is only that of allopathic, or what is called by many as "Western" medicines. It would be much better to discontinue these medications under medical guidance as they may be unknowingly the reason for your erection problems! 

Drugs Causing Sexual Dysfunction

 Drug/Drug Class          

Antiarrhythmics

Amiodarone

Mexiletine        

Anticonvulsants

Carbamazepine

Ethosuximide

Phenytoin        

Antidepressants

Amitriptyline

Amoxapine

Clomipramine

Doxepin

Maprotiline

Protriptyline

Trazodone       

Antihypertensives

Atenolol

Clonidine

Hydralazine

Labetolol

Methyldopa

Metoprolol

Pindolol

Prazosin

Propranolol

Verapamil

Reserpine

Guanethidine

Penbutolol,

Timolol              

Antipsychotic

Chlorpromazine

Haloperidol

Thioridazine

Trifluoperazine

Antispasmodic

Baclofen          

Diuretics

Amiloride

Indapamide

Thiazide diuretics

Spironolactone            

Anti-Ulcer

Cimetidine

Ranitidine

Metoclopramide          

Antihyperlipidemic

Clofibrate        

Non-Steroidal Anti-lnflammatory

Naproxen

Ibuprofen        

ashwagandha

Asvagandha (Rt.)

AsVAGANDHË

Asvagandh¡ consists of dried mature roots of  Withania somnifera Dunal. (Fam.Solanaceae), a perennial shrub, found in waste land, cultivated field and open grounds throughout India, widely cultivated in certain areas of Madhya Pradesh and Rajasthan ,roots collected in winter, washed and cut into short pieces.

 

 

SYNONYMS

 

Sanskrit:        Hayagandh¡, V¡jigandh¡

Assamese:   Ashvagandha

Bengali:        Ashvagandha

English:        Winter cherry

Gujrati:          Asgandha

Hindi:            Asgandh

Kannada:      Angarberu, Hiremaddina-gida

Kashmiri:      Asagandh

Malayalam:   Amukkuram

Marathi:        Asagandha, Askagandha

Oriya:           Aswagandha

Punjabi:        Asgandh

Tamil:           Amukkaramkizangu

Telugu:        Pennerugadda

Urdu :          Asgand

 

Risk Factors for Diabetes

The Risk Factors for Diabetes in Indians Are:

Age— Indians develop diabetes at a very young age, at least 10 to 15 years earlier than the western population. An early occurrence of diabetes gives ample time for development of the chronic complications of diabetes. The incidence of diabetes increases with age. In India, the life span has increased, hence more number of people with diabetes are being detected.

Family History— The prevalence of diabetes increases with a family history of diabetes. The risk of a child developing diabetes with a parental history increases above 50 per cent. A high incidence of diabetes is seen among the first degree relatives. Indians have a high genetic risk for diabetes as observed in Asian Indians who have migrated to other countries. They have been found to have a higher rate of diabetes as compared to the local population .

Central Obesity— The association of obesity with Type II Diabetes is well known. Even with an acceptable body weight range, weight gain could increase the risk of diabetes . An excess of body fat specially concentrated within the abdomen has an increased risk of diabetes. The cut-off limit for waist circumference for Indians have been recommended to be 90 cm for males and 80 cm for females. Abdominal obesity is defined by waist circumference above these limits.

Physical Inactivity and Sedentary Living— There is enough evidence to demonstrate that physical inactivity as a independent factor for the development of type II diabetes. The availability of motorised transport and a shift in occupations combined with the plethora of television programmes has reduced the physical activity in all groups of populations.

Insulin Resistance— Asian Indians have been found to be more insulin resistant as compared to the white population. They have a higher level of insulin to achieve the same the blood glucose control. A cluster of factors consisting of abnormal fats (Dyslipidemia), high blood pressure, obesity, and abnormal glucose levels known as metabolic syndrome is highly prevalent in Asian Indians.
Urbanisation—The developing countries like India are undergoing rapid urbanisation . Urbanisation is associated with increasing obesity, decreasing physical activity due to changes in lifestyle, diet and a change from manual work to less physical occupations.

Stress— The impact of stress both physical and mental along with lifestyle changes has a strong effect of increasing incidence of type II Diabetes amongst persons is a strong genetic background.

srii nandhi ayurvedic clinic

i am very proud to post this news that,we have established our new branch at tiruvallur.with lot of effort by father we made an new srii nandhi ayurvedic clinic.

speciality of srii nandhi...

well build hospital
clean and pleasant environment
panchakarma facility
well stocked medical shop
guidelines of senior Doctors(both Ayurveda & allopathy)
center of the city

speciality of treatment....

traditional way of approach & diagnosis(nadi pariksha)
leading company medicines
individual counselling for every patients

major conditions we take care......

diabetes and diabetes related problems
bone & joint care

FDA study report

Anemia Drugs Linked to Stroke Study Deaths: FDA


Preliminary results from a German study suggest that stroke patients' use of anti-anemia drugs such as Aranesp, Procrit and Epogen might end up boosting their risk for death, the U.S. Food and Drug Administration (FDA) warned on Friday.

The goal of the study was to see if high doses of the anti-anemia drug epoetin alfa could improve the ability of stroke patients to take care of themselves after recovering from a stroke.

The hope was that the drug would be neuroprotective, but use of epoetin alfa now appears linked to a near-doubling of mortality.

This is not the first time that these drugs have come under scrutiny. In the United States, medications like Procrit were marketed heavily as anemia treatments, particularly for cancer patients and those with kidney failure.

However, in July of this year, the FDA called on manufacturers of Aranesp and Procrit to add a warning label that could limit their use for cancer patients.

These changes were spurred by studies that showed these types of medications might cause tumors to spread and also raise patients' risks for bleeding. These findings resulted in an FDA advisory committee recommending in June that while the drugs should remain on the market, they should not be used in patients whose cancer is curable.

The committee also voted to recommend against the drugs' use in patients with breast or head and neck cancer.

The new German study looked at the use of epoetin alfa as an aid to stroke recovery.

"These drugs are not licensed in the United States for this particular use," noted Dr. Kathy Robie-Suh, a team leader in the division of medical imaging and hematology at the Center for Drug Evaluation and Research, part of the FDA's Office of New Drugs and Office of Drug Safety.

"The drug has been approved for about 19 years for treating anemia in patients with acute renal [kidney] failure and in other settings," Robie-Suh said. "Today's warning doesn't have any bearing on the particular label uses of the product in the United States," she said.

The FDA will continue to look into the results of this study, Robie-Suh said. "We have asked for more information about the study. We would certainly like to receive the data, but those data are not in our hands or under our control," she said.

For the trial, 522 stroke patients were randomly assigned to receive relatively high doses of epoetin alfa or a placebo. Some patients were also given R-tPA, a powerful clot-busting drug.

Three months after the start of the trial, 16 percent of the patients who received high doses of the drug epoetin alfa died, compared with 9 percent of patients who were not given the drug, according to the U.S. Food and Drug Administration (FDA).

Among the deaths in the German trial, about 50 percent occurred within the first week after the drug was started. Among those receiving the drug, 4 percent died from bleeding within the brain compared with 1 percent of the patients who were not given the drug.

The FDA said that it expects to receive more data on the study "within the next several weeks," and when the agency's analysis is complete, it will "communicate our conclusions and recommendations to the public."

Friday's FDA notice was issued after Ortho Biotech -- the division of the pharmaceutical giant Johnson and Johnson, which makes Procrit -- alerted the agency to the results of the German trial.

"Ortho Biotech has become aware of preliminary data from an investigator-initiated experimental study of the effects of Epoetin alfa in patients with acute ischemic stroke," the company said in a Sept. 17 statement. "Ortho Biotech has reported this information to the U.S. Food and Drug Administration and to European regulatory authorities. Additional analyses are under way to better understand these preliminary results."

"This study is interesting, because people were looking at potential neuroprotective effects of erythropoiesis-stimulating agents (ESAs)," said Dr. Samuel M. Silver, a spokesman for the American Society of Hematology.

These patients were not anemic, Silver noted. "They were also receiving very powerful clot-busting drugs at the same time as relatively high doses of ESAs. These are not the typical patients in any way shape or form that usually receive these drugs," he said.

Silver doesn't think further action by the FDA is needed. "I don't think the drug needs to be looked at for patients who are currently being treated in this country, but it certainly will give pause to the way studies are being designed to look at the neuroprotective effects of these drugs," he said

Dad's in-home smoking may harm family's health

Fathers-to-be who smoke and want to protect the health of their families should take it outside, suggests new research from Korea.

Newborns whose fathers had smoked in the home had higher levels of nicotine in their hair than babies born to non-smoking dads, Dr. Moon-Woo Seong of the National Center in Goyang and colleagues found. But infants whose fathers smoked, but only did so outdoors, had no more nicotine in their hair than babies whose fathers did not smoke at all.

"Outside smoking substantially reduces maternal and fetal exposure," they conclude.

The study, reported in the latest issue of the American Journal of Epidemiology, included 63 mother-father-newborn trios. None of the mothers in the study were smokers, or were regularly exposed to second-hand smoke outside the home. In 27 families neither parent smoked, fathers only smoked outdoors in 27 of the families, and in 9 families the father smoked indoors.

Mothers living with smokers had significantly more nicotine and its byproduct cotinine in their hair, Seong and colleagues found, but there were no significant difference between nicotine and cotinine levels in the hair of babies with non-smoking fathers and those with smoking fathers.

However, when the researchers looked separately at indoor and outdoor smoking, they did find higher nicotine levels in the children of indoor smokers compared to outdoor smokers.

Based on average nicotine levels, note the researchers, the wife of an indoor smoker is exposed to 7.4 percent of all of the smoke her husband consumes, while 16.7 percent of the smoke a mother inhales is passed to her fetus.

"Our findings," the team concludes, "indicate that paternal smoking inside the home leads to significant fetal and maternal exposure to environmental tobacco smoke. We also found that paternal smoking outside the home helpfully reduces levels of environmental tobacco smoke to which the smoker's wife and her fetus are exposed."

Craving Chocolate? Take a Walk Instead

Craving Chocolate? Take a Walk Instead
Study Shows a Brisk Walk May Help Curb Chocolate Cravings


Chocolate has a special allure for many of us, bordering on the addictive. But a new study shows that taking a brisk walk can cut down the urge to eat chocolate -- and may help curb cravings that can derail weight loss efforts.

When it comes to cravings, chocolate is the most common and "intensely" craved food, according to background information presented with the study findings.

Researchers wanted to look at what goes into an intense craving and how one might break it.

Adrian Taylor and Anita Oliver of the University of Exeter gathered 25 people whom they describe as "regular chocolate eaters" -- those who ate at least two 50-gram bars of chocolate a day.

The chocolate-eaters were deprived of their favorite sweet for three days; they were also told not to exercise or have caffeine for two hours before the test period. Abstaining from chocolate, being under stress, and then exposing someone to chocolate has been shown to ignite cravings for chocolate.

Blood pressure and heart rate were monitored; participants also completed a food-craving questionnaire.

On separate days, one group of participants took a brisk 15-minute walk on a treadmill. They were told to walk as if they were catching a bus, but not until they were out of breath. The comparison group sat quietly for 15 minutes.

After walking or doing nothing, each participant took a computerized test (the stressor) and unwrapped and handled a chocolate bar -- but they were not allowed to eat it.

Researchers found that the group that exercised had a significant reduction in chocolate cravings when compared to their baseline.

Taking a brisk walk also eased blood pressure readings for participants after the mental-challenge test and handling the unwrapped chocolate. Being sedentary did not appear to lessen cravings.

Facts About Food Cravings

In their study, the researchers also provided this background information about food cravings:
Up to 97% of women and 68% of men experience food cravings.
Cravings are usually for dense, calorie-packed foods.
Food cravings often come before a bout of unhealthy eating.

In an introduction to the study, the researchers write that food cravings have been known to be responsible for throwing people off track when they are in treatment programs to lose weight or to recover from an eating disorder.

The researchers hope the findings can help shed light on how to interrupt cravings, since past research has shown that even tiny changes in how much people eat and small increases in exercise can be helpful in keeping weight off and creating good health habits.

The study appears in the latest issue of the journal Appetite.